In 2021, Mr. Sappern led PE-backed HIT company PeriGen through a competitive sales process, culminating in a high value exit for investors. This outcome was the capstone of his efforts to transform an underperforming obstetrical documentation company into the global leader in applying FDA-cleared Artificial Intelligence (AI) to obstetrical care. These efforts led to significant reductions in newborns transferred to the NICU, three consecutive years of double-digit growth in sales, revenue and earnings and a number of national awards for product innovation. Communicative and collaborative, Sappern has had great success forging investor, management and customer alignment. Commercially oriented, he is an enthusiastic, hands-on guide in key account management and business development initiatives. With management experience over the last 20 years leading all operational aspects of a commercial enterprise software company, Sappern has the context and credibility with which to facilitate award-winning product innovation and motivate high-achieving mission-driven organizations that are always informed by key performance metrics.Prior to leading PeriGen, Sappern served as a corporate officer for Eclipsys Corporation before and through its merger with Allscripts. For Eclipsys, Sappern managed P&Ls for the Cloud Hosting and Implementation and Training divisions, after joining the firm as a VP of Product Development. As a result of the merger, Sappern became the new entity’s SVP of Client Sales responsible for more than $500MM in bookings. Sappern served on Allscripts Executive Operating Group until his departure from the company.